Back

Point-of-care high-sensitivity troponin testing for rapid chest pain triage in emergency primary care: preliminary efficacy findings from the OUT-POC Study

29 August 2026 (11:15 - 11:45)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes: new biomarkers for risk stratification and machine learning Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tonje R Johannessen

University of Oslo, Oslo (Norway)

3 More presentations in this session

Presentation thumbnail
Prognostic significance of the advanced lung cancer inflammation index in acute coronary syndrome patients: a systematic review and meta-analysis
Doctor S. Saenz Ancira (Bronx, US)
Abstract Slides
Presentation thumbnail
Pre-procedural machine learning model including prior SGLT2 inhibitor therapy improves early risk stratification for contrast-associated kidney injury in acute coronary syndrome
Doctor J. Andreu Cayuelas (Cartagena, ES)
Abstract Slides
Presentation thumbnail
CRP reveals an inflammatory, non-calcified coronary endotype in SMuRF-less individuals and enables efficient two-stage screening for subclinical atherosclerosis
Doctor S. Fathieh (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Acute coronary syndromes: new biomarkers for risk stratification and machine learning

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Prehospital assessment of the one-hour rule-in/rule-out algorithm using a high-sensitivity cardiac troponin t assay in a low-prevalence population for acute coronary syndrome (OUT-ACS)
2 September 2019
thumbnail
Congress Presentation
Discussant review - WESTCOR-POC
2 September 2024
thumbnail
Congress Presentation
Point-of-care NT-proBNP for the screening of PREGnancy-related Heart Failure - the PREG-HF study
28 August 2022
thumbnail
Congress Presentation
The diagnostic and prognostic value of high-sensitivity troponin T for cardiovascular outcomes in patients receiving immune checkpoint inhibitor therapy.
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources